Althion, a Hyderabad-based water-tech company specializing in ultra-pure water systems, has raised ₹3.6 crores in its pre-Series A funding round from IAN Group-powered BioAngels. The round also saw participation from prominent investors Arun Seth, Om Manchanda, KNK Venkatraman, and Shubham Rastogi.
The fresh capital will be used to pilot the manufacture of 40 units of its innovative tabletop laboratory water purification system and further its R&D efforts on products and solutions aimed at enhancing kidney dialysis efficiency and sustainability. Additionally, the company plans to establish a larger facility to scale its operations.
Surya Rao, Founder, Althion, said, “We are thrilled to announce this funding by BioAngels/India Angels Network Fund to strengthen our R&D and manufacturing push in the area of ultra-pure water production and recycling. We hope to reduce the large quantum of imports in the sector of UPW systems for healthcare, research, and semiconductor industries.”
Padmaja Ruparel, Co-founder, IAN Group, said, “With its small raise, Althion is well on its way to creating a big impact in filling important gaps in healthcare and research, which is exactly in line with the Make in India campaign. They stand out in a very competitive market thanks to their ability to provide top-notch, reasonably priced solutions with an emphasis on sustainability and indigenization. Our faith in Althion’s vision and its ability to transform the water-tech, as they grow and enter new markets, we are thrilled to accompany them on their journey.”
Founded in 2017, Althion develops cutting-edge ultra-pure water systems that serve healthcare, research, and semiconductor industries. The company’s innovations, supported by BIRAC and aligned with the Make in India initiative, are empowering dialysis centres, biotechnology labs, and premier hospitals across the country.
Its proprietary Althion Remote Monitoring System further enhances its competitive advantage by enabling predictive and preventive maintenance. The company’s products are already trusted by renowned institutions, including Sir Ganga Ram Hospital, Homi Bhabha Memorial Cancer Centre, Narayana Hrudayalaya, and Nephroplus centres across India.
The company’s work has already been supported by grants from BIRAC for the development of its tabletop and kidney dialysis products, as well as seed funding from C-Camp Bangalore and AIC CCMB Hyderabad. The company is in the process of securing CDSCO and BIS certifications to strengthen its position in public tenders. Further, it has been approved for funding towards CE marking and USFDA certifications, which will open markets across Latin America, Africa, and Asia.
